Another one after Johnson and Johnson! Lilly suspended new crown drug trials due to safety concerns.

"Safety is the most important thing for Lilly," Lilly spokeswoman Molly McCully said Wednesday, according to the Washington Post, CNBC and other media.
we support the recommendation of DSMB, the independent data security monitoring committee for this trial, to consider a suspension.
shares closed down 2.9 per cent after the announcement.
Lilly's drug is part of a treatment called monoclonal antibody, which is made as an immune cell that scientists hope can be used to fight the new coronavirus.
the treatment uses blood samples from people recovering from neo-coronary pneumonia in the United States.
Lilly, companies such as AstraZeneta are also developing so-called antibody therapies.
news agency said Lilly's announcement came less than 24 hours after Johnson and Johnson had just confirmed that their ongoing research on the new corona vaccine had been suspended because participants had unexplained symptoms.
Johnson and Johnson said in a response to the media that "one participant developed unsealable symptoms" and declined to provide more information.
.